Differences in resting state and task-based EEG measures between patients with major depressive disorder and healthy controls
Our findings suggest the benefits of utilizing objective measures for enhancing our understanding and treatment of the disorder.
Authors
- Silke Miller (ORCID: https://orcid.org/0000-0002-1124-3484)
- Amir H. Meghdadi (ORCID: https://orcid.org/0000-0001-7863-6488)
- Hartmuth C. Kolb (ORCID: https://orcid.org/0000-0003-2414-5792)
- Chris Berka (ORCID: https://orcid.org/0000-0003-1566-2907)
- Peter de Boer (ORCID: https://orcid.org/0000-0002-3987-7462)
- Ziad S. Saad
- Natasha Kovacevic (ORCID: https://orcid.org/0009-0003-1721-7820)
- Maura Furey
Institutions
- Johnson & Johnson (United States) (US)
- Advanced Brain Monitoring (United States) (US)
- Neurocrine Biosciences (United States) (US)
Publication Details
- Journal
- Clinical Neurophysiology
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1016/j.clinph.2025.03.022
- Citations
- 5
- Primary Topic
- Neural and Behavioral Psychology Studies
- Type
- article
- Field-Weighted Citation Impact
- 7.16
Funders
- National Institutes of Health
- Defense Advanced Research Projects Agency
- Janssen Research and Development
- Defense Sciences Office, DARPA